Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Free Cash Flow (2019 - 2025)

Pulmonx has reported Free Cash Flow over the past 7 years, most recently at -$8.1 million for Q3 2025.

  • Quarterly Free Cash Flow rose 2.84% to -$8.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$25.3 million through Dec 2025, up 20.31% year-over-year, with the annual reading at -$31.8 million for FY2024, 15.79% up from the prior year.
  • Free Cash Flow was -$8.1 million for Q3 2025 at Pulmonx, down from -$3.7 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$3.7 million in Q2 2025 and troughed at -$15.6 million in Q1 2022.
  • The 5-year median for Free Cash Flow is -$9.9 million (2022), against an average of -$9.8 million.
  • Year-over-year, Free Cash Flow crashed 69.56% in 2021 and then skyrocketed 33.52% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at -$11.8 million in 2021, then increased by 23.29% to -$9.1 million in 2022, then increased by 7.01% to -$8.5 million in 2023, then skyrocketed by 33.52% to -$5.6 million in 2024, then plummeted by 44.67% to -$8.1 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Free Cash Flow are -$8.1 million (Q3 2025), -$3.7 million (Q2 2025), and -$13.5 million (Q1 2025).